You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
遠大醫藥(00512.HK)附屬擬5198萬元收購武漢遠大弘元10%股權並將持有其100%權益
格隆匯 07-13 17:17

格隆匯7月13日丨遠大醫藥(00512.HK)發佈公吿,2021年7月13日,公司附屬遠大醫藥(中國)有限公司作為買方與賣方(即武漢三鎮實業控股股份有限公司)訂立收購協議,據此,賣方同意出售標的企業10%股本權益,累計代價為人民幣5198萬元,將會由買方以現金支付。

標的企業(即武漢遠大弘元股份有限公司)為一間在2000年於中國成立的股份制有限責任公司。標的企業的註冊股本是人民幣5000萬元,並已全額繳足。於該公吿日期,標的企業由買方持有90%及賣方持有10%。

標的企業專注氨基酸及其衍生物的研發及生產,並受惠於武漢大學及湖北省氨基酸工程技術研究中心的研究成果,致力於生物醫學領域產品的高新技術產業化。標的企業擁有嚴謹的品質保證體系,通過了多項中國及國際性的品質管理系統認證。

標的企業亦為氨基酸國家標準和行業標準的起草單位之一,其產品質量管理系統已根據多個國際性及本地品質標準被核證。標的企業擁有進行進出口業務的授權證照。其品牌“WUBC”和“WHUHOYO”為氨基酸領域中的國際性知名品牌。

標的企業已通過中國最新版的GMP認證,現擁有乙酰酪氨酸、乙酰半胱氨酸、鹽酸半胱氨酸、羧甲司坦、鹽酸精氨酸、鹽酸組氨酸、鹽酸賴氨酸等多個生產批文,另有數個新產品的生產批文正在審批之中。

公司表示,自集團收購了標的企業的90%權益後,標的企業展示了健康的增長及可靠的前景。董事會相信收購事項將可使集團增加於標的企業的股權及整合對標的企業的控制,以成為中國最具競爭力的氨基酸生產商之一。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account